Multimodal Physiotherapy Intervention for People With Migraine
Official title: What is the Effectiveness of an Evidence-based Multimodal Intervention When Compared With Conventional Physiotherapy, and Which Factors Determine Treatment Success in Patients With Migraine- a Pilot Study
Run by Hochschule Osnabruck · NCT07671703 · Data updated 2026-11-12
A multimodal physiotherapy program is being tested to see if it helps adults with migraine feel better and function more in daily life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 195 (estimated) |
| Sponsor | Hochschule Osnabruck Academic / other |
| Locations | 1 site (Osnabrück, Low Saxony) |
| Status | Recruiting |
| Started | February 11, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT07671703 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-70 with a confirmed migraine diagnosis (episodic or chronic) experiencing headaches on at least 2 days per month for the past 3 months.
✕Probably not a fit
Individuals with other primary or secondary headache disorders, significant comorbidities, or recent physiotherapy for headache or neck pain may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates a structured multimodal physiotherapy program that combines patient education, aerobic endurance training, targeted exercises, relaxation, and self-management strategies for migraine management. Participants aged 18 to 70 with chronic or episodic migraine receive the multimodal treatment or usual care in a real-world setting. The study aims to determine whether the integrated approach improves quality of life, reduces migraine-related disability, and is feasible in routine clinical practice. The program emphasizes evidence-based components and personalized adaptation to the patient’s needs, with outcomes assessed over a defined follow-up period.
Why it matters
Potential benefit: If successful, participants may experience reduced migraine burden and better daily functioning through a non-drug, non-invasive treatment approach.
How similar studies have gone: Previous work supports multimodal physiotherapy approaches for migraine, but pragmatic randomized data in routine practice remain limited, making this study important to validate real-world effectiveness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Aged 18-70 years. * Have a diagnosis of migraine established by a headache specialist according to the International Classification of Headache Disorders, 3rd edition (ICHD-3). * Have experienced migraine symptoms for more than 3 months, with headaches occurring on at least 2 days per month. * Provide written informed consent before participation. * Complete a study-specific self-assessment questionnaire based on the ICHD-3 criteria to confirm the migraine diagnosis and classify participants as having episodic or chronic migraine. Exclusion Criteria * Other primary or secondary headache disorders. * Acute neurological diseases or abnormal neurological examination findings. * Rheumatic diseases, vascular diseases, cancer, or other serious medical conditions. * Comorbid chronic pain disorders (e.g., fibromyalgia). * Diagnosed psychiatric disorders (e.g., major depression or schizophrenia). * Substance abuse. * Physiotherapy for headache or neck pain within 3 months before study enrolment. * Previous surgery involving the jaw, cervical spine, or head. * Pregnancy. * Pain not clearly attributable to migraine. * Inability or unwillingness to provide informed consent. * There are no restrictions regarding sex, ethnicity, or country of residence.
Where it's running
-
Capu Motion: Die Physio- und Ergotherapeuten GbR
Osnabrück, Low Saxony, Germany Recruiting
Study contacts
- Study coordinator: Marie Marks MM Marks, Bachelor in Physiotherapy
- Email: marieKempe@web.de
- Phone: +49 170 3079512
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote electrical neuromodulation to test pain inhibition in migraine and fibromyalgia
We’re testing if the Nerivio wearable can boost the body’s natural pain-inhibition system (CPM) and reduce pain more than a sham device in adults with migraine or fibromyalgia.
-
Elismetrep (K-304) for acute treatment of migraine
This study tests whether a single dose of elismetrep can quickly lessen the pain of a migraine compared with placebo in adults 18 to 75.
-
Magnesium sulfate for acute non-traumatic headache in the ED: 2 g vs 4 g vs standard paracetamol
This study tests whether intravenous magnesium sulfate given in different doses helps adults with acute non-traumatic headache in the emergency department, compared with paracetamol.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Online Hatha Yoga Add-On for High-Frequency Episodic Migraine
This trial tests whether a 12-week online Hatha yoga program added to usual migraine treatment can help adults with high-frequency episodic migraine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.